The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

6 articles for K Yokota


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis and structure-activity relationships of novel selective factor Xa inhibitors with a tetrahydroisoquinoline ring.EBI
Central Pharmaceutical Research Institute
Discovery of novel tetrahydroisoquinoline derivatives as potent and selective factor Xa inhibitors.EBI
Central Pharmaceutical Research Institute
Structure-activity relationships of potent and selective factor Xa inhibitors: benzimidazole derivatives with the side chain oriented to the prime site of factor Xa.EBI
Central Pharmaceutical Research Institute
Structural basis for the inhibitor recognition of human Lyn kinase domain.EBI
Osaka Prefecture University
Azasugar-based MMP/ADAM inhibitors as antipsoriatic agents.EBI
Hokkaido Collaboration Center N-21
New strategy for antedrug application: development of metalloproteinase inhibitors as antipsoriatic drugs.EBI
Organon K.K.